Onc Now: Episode 18: What’s New from ESGO 2025?

In this two-part series host Jonathan Sackier is joined by Bradley Monk, a pioneering figure in gynaecologic oncology. In Part 1, they discuss key updates from the European Society of Gynaecological Oncology (ESGO) Congress, including the updated ESGO-ESTRO-ESP endometrial cancer guidelines and the latest results from the KEYLYNK-001 study in ovarian cancer. With reflections from his three-decade career, Monk provides actionable takeaways for clinicians and researchers alike. Stay tuned for Part 2, where they delve into insights from SGO 2025. 

Timestamps: 

00:00 - Quickfire questions 
04:55 - Career milestones 
07:10 - ESGO 2025 standout sessions 
09:52 - KEYLYNK-001 trial & takeaways 
13:52 - New endometrial cancer staging